Erythropoietic Agents and the Elderly
- 31 October 2008
- journal article
- review article
- Published by Elsevier BV in Seminars in Hematology
- Vol. 45 (4), 267-275
- https://doi.org/10.1053/j.seminhematol.2008.06.007
Abstract
No abstract availableKeywords
This publication has 102 references indexed in Scilit:
- Venous Thromboembolism and Mortality Associated With Recombinant Erythropoietin and Darbepoetin Administration for the Treatment of Cancer-Associated AnemiaJAMA, 2008
- A Gain-of-Function Mutation in theHIF2AGene in Familial ErythrocytosisNew England Journal of Medicine, 2008
- HIF–prolyl hydroxylase inhibition results in endogenous erythropoietin induction, erythrocytosis, and modest fetal hemoglobin expression in rhesus macaquesBlood, 2007
- Hypoxia-inducible factor–2 (HIF-2) regulates hepatic erythropoietin in vivoJCI Insight, 2007
- Phase II study of two dose schedules of C.E.R.A. (Continuous Erythropoietin Receptor Activator) in anemic patients with advanced non-small cell lung cancer (NSCLC) receiving chemotherapyTrials, 2007
- Acute postnatal ablation of Hif-2 α results in anemiaProceedings of the National Academy of Sciences of the United States of America, 2007
- Growth factor receptors as regulators of hematopoiesisBlood, 2006
- A class of iron chelators with a wide spectrum of potent antitumor activity that overcomes resistance to chemotherapeuticsProceedings of the National Academy of Sciences, 2006
- Discovering erythropoietin's extra-hematopoietic functions: Biology and clinical promiseKidney International, 2006
- Erythropoietin reduces perihematomal inflammation and cell death with eNOS and STAT3 activations in experimental intracerebral hemorrhageJournal of Neurochemistry, 2006